Alnylam Pharmaceuticals
ALNY
#584
Rank
โ‚ฌ30.44 B
Marketcap
235,24ย โ‚ฌ
Share price
-2.24%
Change (1 day)
67.72%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company